CD27/CD70 interaction directly induces natural killer cell killing activity

被引:60
作者
Yang, FC
Agematsu, K
Nakazawa, T
Mori, T
Ito, S
Kobata, T
Morimoto, C
Komiyama, A
机构
[1] SHINSHU UNIV,SCH MED,DEPT PEDIAT,MATSUMOTO,NAGANO 390,JAPAN
[2] HARVARD UNIV,SCH MED,CHARLES A DANA RES INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
关键词
D O I
10.1111/j.1365-2567.1996.tb00017.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The CD27 molecule is expressed on a portion of natural killer (NK) cells as well as T and B cells. To provide the functional capacity of CD27 molecule on NR cells, we here highly purified CD3(-)CD56(+) NK cells by flow cytometry (purity > 98%), and investigated their NK cell activity via CD27/CD70 interaction using a CD70-transfectant by a 4 h Cr-51-release assay. The enhancement of NK activity by purified NK cells in the presence of interleukin-2 (IL-2) or interleukin-12 (IL-12) against CD70/Nalm-6 was not recognized as compared to against mock/Nalm-6. However, after a coculture with the fixed CD70/300-19, the purified NK cells increased the NK cell activity against K562, the value being 10 to 20% higher than coculture with the mock/300-19 in the presence of IL-2 or IL-12. The enhancement of NK activity was blocked by the addition of anti-CD70 monoclonal antibody (mAb). In addition, conjugation of NK cells to the target was increased by coculture with the CD70/300-19 without increased expression of adhesion molecules. In the parallel experiment, there was no increase in the killing capacity of NK cells. These results strongly show that CD27/CD70 interaction directly enhances NK activity in the presence of IL-2 or IL-12 by increasing the effector and target conjugate formation, indicating that CD27/CD70 interaction plays an important role in the cytotoxic function of NK cells.
引用
收藏
页码:289 / 293
页数:5
相关论文
共 22 条
[1]  
AGEMATSU K, 1995, J IMMUNOL, V154, P3627
[2]   CD28 INTERACTION WITH B7-COSTIMULATES PRIMARY ALLOGENEIC PROLIFERATIVE RESPONSES AND CYTOTOXICITY MEDIATED BY SMALL, RESTING LYMPHOCYTES-T [J].
AZUMA, M ;
CAYABYAB, M ;
BUCK, D ;
PHILLIPS, JH ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :353-360
[3]  
BOWMAN MR, 1994, J IMMUNOL, V152, P1756
[4]  
GALANDRINI R, 1994, J IMMUNOL, V153, P4399
[5]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A LIGAND FOR CD27 DEFINES A NEW FAMILY OF CYTOKINES WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR [J].
GOODWIN, RG ;
ALDERSON, MR ;
SMITH, CA ;
ARMITAGE, RJ ;
VANDENBOS, T ;
JERZY, R ;
TOUGH, TW ;
SCHOENBORN, MA ;
DAVISSMITH, T ;
HENNEN, K ;
FALK, B ;
COSMAN, D ;
BAKER, E ;
SUTHERLAND, GR ;
GRABSTEIN, KH ;
FARRAH, T ;
GIRI, JG ;
PATRICIABECKMANN, M .
CELL, 1993, 73 (03) :447-456
[6]  
HERBERMAN RB, 1981, SCIENCE, V24, P214
[7]   CD27-CD70 INTERACTIONS REGULATE B-CELL ACTIVATION BY T-CELLS [J].
KOBATA, T ;
JACQUOT, S ;
KOZLOWSKI, S ;
AGEMATSU, K ;
SCHLOSSMAN, SF ;
MORIMOTO, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11249-11253
[8]  
KOBATA T, 1994, J IMMUNOL, V153, P5422
[9]  
KOMIYAMA A, 1985, BLOOD, V66, P99
[10]   A NEW SUPERFAMILY OF CELL-SURFACE PROTEINS RELATED TO THE NERVE GROWTH-FACTOR RECEPTOR [J].
MALLETT, S ;
BARCLAY, AN .
IMMUNOLOGY TODAY, 1991, 12 (07) :220-223